Skip to content
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us

News

James McCutcheon FCCA, Appointed Chief Financial Officer

By DA

James McCutcheon FCCA, Appointed Chief Financial Officer Read More »

Julie Davis, Appointed Head of Quality Management

By DA

Julie Davis, Appointed Head of Quality Management Read More »

Jon Barnett PhD, Appointed Head of CMC and Supply Chain

By DA

Jon Barnett PhD, Appointed Head of CMC and Supply Chain Read More »

Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress 2020

By DA

Abstract for Presentation at the European League Against Rheumatism (EULAR) Congress 2020 Read More »

Druin Burch FRCP, Appointed Chief Scientific Officer (CSO)

By DA

Druin Burch FRCP, Appointed Chief Scientific Officer (CSO) Read More »

Abstract for Presentation at the American Congress of Rheumatology (ACR) Congress 2019

By DA

Abstract for Presentation at the American Congress of Rheumatology (ACR) Congress 2019 Read More »

Pat Butler, Joins as Board Observer and Advisor.

By DA

Pat Butler, Joins as Board Observer and Advisor. Read More »

Serac Healthcare founded to develop a molecular imaging agent to help rheumatologists manage treatment decisions in their patients with rheumatoid arthritis

By DA

Serac Healthcare founded to develop a molecular imaging agent to help rheumatologists manage treatment decisions in their patients with rheumatoid arthritis Read More »

← Previous 1 2 3

Get in Touch

Reach out to us via email
info@seraclifesciences.com

Connect with Us

Follow us on social media
Follow us on LinkedIn
Serac Healthcare Limited Ltd is a wholly owned subsidiary of Serac Life Sciences Ltd.
Our Focus
  • Endometriosis
  • Inflammatory Arthritis
  • Pipeline
Our Technology
  • Molecular Imaging
  • 99mTc-maraciclatide
  • Publications
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities.
Registered Office: 6th Floor, Charlotte Building, 17 Gresse Street, London W1T 1QL.
Company Number: 11074844. VAT No: 288 9284 31.

Copyright © 2024 by Serac Healthcare Ltd. | Privacy Policy

Powered by Webtec